Skip to content
Search

Latest Stories

Pharmaceutical companies donate cash, medicine to Ukraine

In support of those affected by the war in Ukraine, pharmaceutical companies have come together to donate five-figure cash and source crucial supplies.

Redditch based independent wholesaler Lexon, which was formed in 1992 and works with independent pharmacies across the UK, has made a five-figure cash donation to the Disaster Emergency Committee’s Ukraine Humanitarian Appeal.


While Lexon’s ongoing charity activity usually focuses on causes local to its distribution centres across the UK, the exceptional circumstances in Ukraine prompted its management to make this significant donation.

It has also worked with Jade Pharmaceuticals to provide medicinal supplies to the support effort, to be distributed by a leading care organisation.

Anup Sodha, managing director at Lexon, said: “We are deeply saddened to witness events unfolding in the Ukraine and wanted to make a gesture to show our support in any way we can.

“Many of our staff across our distribution centres have expressed their desire to show some support for those impacted and we shared that sentiment.

“Real, practical assistance is what is needed right now, so we are proud to contribute to the Disaster Emergency Committee, who are doing incredible work.

“We have a diverse team across our sites with people affected by this in different ways, so we will continue to offer support to individuals who want to carry out their own fundraising or provide aid packages.”

Neal Radia, owner of Jade Pharmacy -- a group of 20 community pharmacies based in North West London and Hertfordshire -- said: “We are proud to have offered support in any way we can, this is the right thing to do and I encourage anyone who can help at all to do so.”

The DEC’s appeal has raised more than £200million so far, with the organisation saying it is ‘grateful to everyone who is giving, organising events and helping to spread the word.’

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less